Details for Patent: 7,858,740
✉ Email this page to a colleague
Title: | Exendin agonist compounds |
Abstract: | Novel exendin agonist compounds are provided. These compounds are useful in treating Type I and II diabetes and conditions which would be benefited by lower plasma glucose and delaying and/or slowing gastric emptying. |
Inventor(s): | Beeley; Nigel Robert Arnold (La Jolla, CA), Prickett; Kathryn S. (San Francisco, CA) |
Assignee: | Amylin Pharmaceuticals, Inc. (San Diego, CA) |
Filing Date: | Aug 28, 2006 |
Application Number: | 11/511,738 |
Claims: | 1. A peptide comprising the amino acid sequence of SEQ ID NO:5. 2. The peptide of claim 1 in the form of a pharmaceutically acceptable salt. 3. A composition comprising the peptide of claim 1 and a pharmaceutically acceptable carrier. 4. A peptide comprising the amino acid sequence of SEQ ID NO: 37, 31, or 32. 5. The peptide of claim 4 in the form of a pharmaceutically acceptable salt. 6. A composition comprising the peptide of claim 4 and a pharmaceutically acceptable carrier. 7. The peptide of claim 4, wherein the peptide comprises the amino acid sequence of SEQ ID NO:37. 8. The peptide of claim 4, wherein the peptide comprises the amino acid sequence of SEQ ID NO:31. 9. The peptide of claim 4, wherein the peptide comprises the amino acid sequence of SEQ ID NO:32. |